Transparency Market Research offers to its readers a well-researched document about the global narcolepsy market . The research report, titled “Narcolepsy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,” provides an insightful take on the market drivers and restraints as well as an explanation of the trends and dynamics present in the market. The research report has been compiled using primary and secondary analyses. Furthermore, it also uses SWOT analysis to highlight the strengths, weaknesses, opportunities, and threats prevalent in the market. The expert industry analysts have also studied the historical data pertaining to the global narcolepsy market and compared it with the current market situation to chart a trajectory for the market in the coming years.

Narcolepsy is a neurological disorder that causes a disturbance in an individual’s sleep-wake cycle. This disorder is caused due to a genetic abnormality, which may be a result of biological and environmental factors. Those suffering from narcolepsy show symptoms of excessive daytime sleepiness (EDS) and erratic night sleep patterns. Many a time, this disorder is misunderstood as insomnia. Other symptoms of this disorder are hypnagogic hallucinations, cataplexy, automatic behavior, sleep paralysis, and night weakness.

The global narcolepsy market is primarily being driven by the high incidence of narcolepsy, growing awareness about the disorder, and rising demand for treating narcolepsy. Statistics show that there are over 3 million people suffering from narcolepsy all over the world, which makes the disorder as common as multiple sclerosis and Parkinson’s disease and more common than cystic fibrosis. Introduction of innovative drugs to treat the disorder and other treatment options is also fueling the growth of this market.

Geographically, this market is segmented into North America, Asia Pacific, Europe, and Rest of the World. Currently, North America holds the largest share in the global narcolepsy market, which is closely followed by Europe. This is attributable to the growing number of cases of narcolepsy in the region. However, analysts predict that Asia Pacific will show the fastest growth rate in this market in the coming years due to the increasing number of treatment options and increasing purchasing power of patients.

Some of the key players operating in the global narcolepsy market are Addrenex Pharmaceuticals, Inc., BIOPROJET, Arena Pharmaceuticals, Inc., Evotec AG, Cephalon, Inc., Graymark Healthcare, Inc., Jazz Pharmaceuticals, Inc., Hypnion, Inc., Teva Pharmaceutical Industries Ltd., and Ligand Pharmaceuticals, Inc. The research report gives a thorough analysis of the research and development activities, product portfolio, investment outlook, financial overview, and strategic mergers and acquisitions of these companies. Furthermore, it also explains the competitive landscape of the global narcolepsy market with the help of Porter’s five forces analysis.

Access Free Sample Report Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2362